LEIDEN, Netherlands — Dutch biopharmaceutical company Crucell announced March 8 that Jerald C. Sadoff was appointed chief medical officer will be a member of its management committee.
Before joining Crucell Sadoff worked at the Aeras Global TB Vaccine Foundation, where he became president and CEO in June 2003. While at Aeras, Sadoff developed four tuberculosis vaccine candidates, two of which are being tested in Africa in Phase IIB efficacy trials.
At Merck, Sadoff led the efforts to develop and obtain licensure for eight licensed vaccines. He also contributed to the development of Merck's HPV vaccine Gardasil.
At the Walter Reed Army Institute of Research, he worked on vaccines against bacterial, viral and parasitic diseases, including sepsis, gonorrhea, cholera, shigella, dengue, HIV and malaria.
Sadoff is chairman of the Malaria Vaccine Scientific Consultants Group at the U.S. Agency for International Development. He also is chairman of several scientific advisory boards for HIV vaccine efforts sponsored by the National Institutes of Health. He serves on the AIDS Vaccine Research Working Group at the National Institute of Allergy and Infectious Disease and the Scientific Advisory Board of the International AIDS Vaccine Initiative.